Urinary 18,19-dihydroxycorticosterone and 18-hydroxy-19-norcorticosterone excretion in patients with primary and secondary aldosteronism
- 30 November 1991
- Vol. 56 (11), 566-570
- https://doi.org/10.1016/0039-128x(91)90015-n
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Identification and implications of new types of mineralocorticoid hypertensionJournal of Steroid Biochemistry, 1989
- 18,19-Dihydroxycorticosterone: A New Metabolite in Human UrineEndocrine Research, 1989
- The Hypertensinogenic Activity of 18-Hydroxy-19-Norcorticosterone in the Adrenalectomized RatAmerican Journal of Hypertension, 1988
- Mineralocorticoid Activity of 19-Hydroxyaldosterone, 19-Nor-Aldosterone, and 3β-Hydroxy-Δ5-Aldosterone: Relative Potencies Measured in Two Bioassay Systems*Endocrinology, 1986
- Synthesis of 18,19-dihydroxycorticosteroneSteroids, 1986
- The effects of 19-nor-aldosterone on blood pressure of adrenalectomized spontaneously hypertensive ratsSteroids, 1985
- The Regulation of Urinary Free 19-Nor-Deoxycorticosterone and its Relationto Systemic Arterial Blood Pressure in Normotensive and Hypertensive Subjects*Journal of Clinical Endocrinology & Metabolism, 1983
- Isolation and identification of 18-hydroxycortisol from the urine of patients with primary aldosteronism.Journal of Biological Chemistry, 1982
- Elevated ‘free’ 18-hydroxy-corticosterone excretion as a possible indicator for early diagnosis of primary aldosteronismThe Journal of Steroid Biochemistry and Molecular Biology, 1981
- Adrenocortical factors in hypertension: I. Significance of 18-hydroxy-11-deoxycorticosteroneThe American Journal of Cardiology, 1976